Divergent routes to oral cancer

Cancer Research

Volumn 66, Issue 15, 2006, Pages 7405-7413

  Hunter, Keith D ^a   Thurlow, Johanna K ^a   Fleming, Janis ^a   Drake, Paul J H ^a   Vass, J Keith ^a   Kalna, Gabriela ^b   Higham, Des J ^b   Herzyk, Pawel ^c   MacDonald, D Gordon ^a   Parkinson, E Ken ^a,d   Harrison, Paul R ^a,e  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d Institute of Cell and Molecular Science   (United Kingdom)

^e BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16INK4A; PROTEIN P53;

ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER STAGING; CELL HETEROGENEITY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; DYSPLASIA; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MOUTH CANCER; MUTATION; ORAL BIOPSY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; HUMANS; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33747878088     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0186     Document Type: Article

References (50)

1. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff KH. A genetic explanation of Slaughters concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-30.
2. Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell 2004;5:311-6.
3. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 1996;56:2484-7.
4. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
5. Reichart PA, Philipsen HP. Oral erythroplakia-a review. Oral Oncol 2005;41:551-61.
6. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005;5:127-35.
7. Ha PK, Benoit NE, Yochem R, et al. A transcriptional progression model for head and neck cancer. Clin Cancer Res 2003;9:3058-64.
8. Burns JE, Baird MC, Clark LJ, et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 1993;67:1274-84.
9. Edington KG, Loughran OP, Berry IJ, Parkinson EK. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinog 1995;13:254-65.
10. McGregor F, Wagner E, Felix D, Soutar D, Parkinson K, Harrison PR. Inappropriate retinoic acid receptor-β expression in oral dysplasias: correlation with acquisition of the immortal phenotype. Cancer Res 1997;57:3886-9.
11. McGregor F, Muntoni A, Fleming J, et al. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer Res 2002;62:4757-66.
12. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-93.
13. Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 2004;573:83-92.
14. Breitling R, Amtmann A, Herzyk P. Iterative Group Analysis (iGA): a simple tool to enhance sensitivity and facilitate interpretation of microarray experiments. BMC Bioinformatics 2004;5:34.
15. Kluger Y, Basri R, Chang JT, Gerstein M. Spectral biclustering of microarray data: coclustering genes and conditions. Genome Res 2003;13:703-16.
16. Higham DJ, Kalna G, Vass JK. Analysis of the singular value decomposition as a tool for processsing microarray expression data. In: Handlovicova A, Krive Z, Mikula K, Sevcovik D, editors. Proceedings of the ALGORITMY 17th Conference on Scientific Computing. Slovak university of Technology: 2005. p. 250-9.
17. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nucleic Acids Res 2002;30:e36.
18. Muntoni A, Fleming J, Gordon KE, et al. Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-β: but p53 mutations are not necessarily required. Oncogene 2003;22:7804-8.
19. Burns JE, Clark LJ, Yeudall WA, et al. The p53 status of cultured human premalignant oral keratinocytes. Br J Cancer 1994;70:591-5.
20. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95:1772-83.
21. Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981;41:1657-63.
22. Higham DJ, Kibble M, Kalna G. Spectral clustering and its use in bioinformatics. J Comput Appl Math. In press 2006.
23. Gordon KE, Ireland H, Roberts M, et al. High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma. Cancer Res 2003;63:458-67.
24. Grose R. Common ground in the transcriptional profiles of wounds and tumors. Genome Biol 2004;5:228.
25. Edington KG, Berry IJ, O'Prey M, et al. Multistage head and neck squamous cell carcinoma. In: Pfragner R, Freshney RI, editors. Culture of human tumor cells. New York: Wiley-Liss; 2004. p. 261-88.
26. Baek JH, Lee G, Kim SN, et al. Common genes responsible for differentiation and senescence of human mucosal and epidermal keratinocytes. Int J Mol Med 2003;12:319-25.
27. Kang MK, Kameta A, Shin KH, Baluda MA, Kim HR, Park NH. Senescence-associated genes in normal human oral keratinocytes. Exp Cell Res 2003;287:272-81.
28. Chung CH, Parker JS, Karaca G, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004;5:489-500.
29. Cromer A, Carles A, Millon R, et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 2004;23:2484-98.
30. Roepman P, Wessels LFA, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005;37:182-6.
31. O'Donnell RK, Kupferman M, Wei SJ, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005;24:1244-51.
32. Wei CL, Wu Q, Vega VB, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006;124:207-19.
33. Sharpless NE, DePinho RA. Cancer: crime and punishment Nature 2005;436:636-7.
34. Loughran O, Clark LJ, Bond J, et al. Evidence for the inactivation of multiple replicative life span genes in immortal human squamous cell carcinoma keratinocytes. Oncogene 1997;14:1955-64.
35. Shimada Y, Maeda M, Watanabe G, et al. Cell culture in esophageal squamous cell carcinoma and the association with molecular markers. Clin Cancer Res 2003;9:243-9.
36. Blons H, Laurent-Puig P. TP53 and head and neck neoplasms. Hum Mutat 2003;21:252-7.
37. Derynck R, Akhurst RJ, Baimain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-29.
38. Malliri A, Yeudall WA, Nikolic M, Crouch DH, Parkinson EK, Ozanne B. Sensitivity to transforming growth factor β 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events. Cell Growth Differ 1996;7:1291-304.
39. Prime SS, Eveson JW, Stone AM, et al. Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-β 1. J Pathol 2004;203:927-32.
40. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-50.
41. Hiratsuka H, Imamura M, Ishii Y, Kohama G, Kikuchi K. Immunohistologic detection of lymphocyte subpopulations infiltrating in human oral cancer with special reference to its clinical significance. Cancer 1984;53:2456-66.
42. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864-70.
43. Blais A, Dynlacht BD. Hitting their targets: an emerging picture of E2F and cell cycle control. Curr Opin Genet Dev 2004;14:527-32.
44. Loughran O, Malliri A, Owens D, et al. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene 1996;13:561-8.
45. Nicolas M, Wolfer A, Raj K, et al. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 2003;33:416-21.
46. Rangarajan A, Talora C, Okuyama R, et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 2001;20:3427-36.
47. Gure AO, Stockert E, Scanlan MJ, et al. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci U S A 2000;97:4198-203.
48. Shimada H, Nakashima K, Ochiai T, et al. Serological identification of tumor antigens of esophageal squamous cell carcinoma. Int J Oncol 2005;26:77-86.
49. Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004;4:876-90.
50. Xu G, Zhang W, Ma MK, McLeod HL. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. Clin Cancer Res 2002;8:2605-11.